Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.42 |
| ▸ | ACACA | Q13085 | 4/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | DHODH | Q02127 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | MYC | P01106 | 1/20 | 0.38 |
| ▸ | CTRC | Q99895 | 1/20 | 0.38 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29293177 | 0.97 | LIMK1 (0.47) | LIMK1MEN1KMT2ACYP19A1ACACA | |
| SCHEMBL29293023 | 0.94 | LIMK1 (0.49) | LIMK1MEN1KMT2AACACAALOX5 | |
| SCHEMBL29293101 | 0.90 | KDM4E (0.47) | LIMK1MEN1KMT2ACYP19A1ACACA | |
| SCHEMBL29293200 | 0.90 | MEN1 (0.47) | LIMK1MEN1KMT2AACACAALOX5 | |
| SCHEMBL29293054 | 0.89 | CYP19A1 (0.58) | LIMK1MEN1KMT2ACYP19A1ALOX5 | |
| SCHEMBL29293027 | 0.89 | MEN1 (0.55) | LIMK1MEN1KMT2AACACAALOX5 | |
| SCHEMBL29293138 | 0.89 | MEN1 (0.55) | LIMK1MEN1KMT2AACACAALOX5 | |
| SCHEMBL23731104 | 0.88 | MEN1 (0.51) | LIMK1MEN1KMT2AACACAALOX5 | |
| SCHEMBL29293103 | 0.88 | MEN1 (0.50) | LIMK1MEN1KMT2AACACAALOX5 | |
| SCHEMBL29294123 | 0.87 | MYC (0.52) | LIMK1MEN1KMT2AKDM4EMYC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228470-A1 | Organic Compound And Organic Light Emitting Device Including Same | P&H TECH CO., LTD (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240228470-A1 | Organic Compound And Organic Light Emitting Device Including Same | P&H TECH CO., LTD (KR) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228470-A1 | Organic Compound And Organic Light Emitting Device Including Same | OR10J3, ORMDL3, OR51E2 | LIMK1 75/4885MEN1 3157/4885KMT2A 1521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.